ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 25 filers reported holding ARGOS THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | -100.0% | 156 | -99.8% | 0.00% | – |
| Q3 2017 | $17,000 | +1600.0% | 94,007 | +2061.1% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 4,350 | +262.5% | 0.00% | – |
| Q1 2017 | $1,000 | -96.7% | 1,200 | -80.5% | 0.00% | – |
| Q4 2016 | $30,000 | +30.4% | 6,144 | +30.7% | 0.00% | – |
| Q3 2016 | $23,000 | -63.5% | 4,700 | -54.1% | 0.00% | – |
| Q2 2016 | $63,000 | +384.6% | 10,237 | +411.8% | 0.00% | – |
| Q1 2016 | $13,000 | 0.0% | 2,000 | -27.1% | 0.00% | – |
| Q3 2015 | $13,000 | -13.3% | 2,744 | +58.1% | 0.00% | – |
| Q1 2015 | $15,000 | – | 1,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $5,984,000 | 15.97% |
| Pharmstandard International S.A. | 5,120,604 | $2,314,000 | 6.17% |
| SANDERS MORRIS HARRIS LLC | 290,424 | $132,000 | 0.02% |
| WEDBUSH SECURITIES INC | 63,500 | $29,000 | 0.00% |
| Virtu KCG Holdings LLC | 127,073 | $57,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $90,000 | 0.00% |
| WASATCH ADVISORS LP | 186,900 | $85,000 | 0.00% |
| STATE STREET CORP | 184,194 | $82,000 | 0.00% |
| SG Americas Securities, LLC | 17,652 | $8,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 398 | $0 | 0.00% |